Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Lifesafe Holdings (LIFS) by Steve Moore in ShareProphets
- Buy Associated British Foods (ABF) by Shore Capital
- Buy Paragon Banking Group (PAG) by Shore Capital
- Buy IG Design Group (IGR) by Canaccord Genuity
- Buy AO World (AO.) by Shore Capital
- Buy Auto Trader Group (AUTO) by Shore Capital
- Hold Kainos Group (KNOS) by Canaccord Genuity
- Buy Property Franchise Group (TPFG) by Canaccord Genuity
- Buy Warehouse Reit (WHR) by Shore Capital
- Buy Team17 Group (TM17) by Shore Capital
- Avoid Verici DX (VRCI) by Steve Moore in ShareProphets
- Buy Diageo (DGE) by Stephen Wright in The Motley Fool
- Buy GSK (GSK) by Chris Bailey in ShareProphets
- Underperform Auto Trader Group (AUTO) by Credit Suisse
- Underweight Rio Tinto (RIO) by JP Morgan
- Overweight Pearson (PSON) by JP Morgan
- Buy Paragon Banking Group (PAG) by JP Morgan
- Buy Domino's Pizza Group (DOM) by Peel Hunt
- Add NewRiver REIT (NRR) by Peel Hunt
- Buy Gooch & Housego (GHH) by Peel Hunt
Immupharma (IMM)
Health Care Sector
Members only
To view this content and much more please Sign Up
NOTE: This is based on 7 open tips for this company
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Immupharma Overview
ImmuPharma PLC is a pharmaceutical development company focusing on developing novel medicines in specialist markets with serious unmet need. Lupuzor is the company's most advanced drug in development and is a treatment for lupus, a life threatening autoimmune disease and has now completed dosing Lupus patients in its Phase III pivotal trial. This is only part of our story as our scientists and researchers are developing drugs to make life changing difference to peoples lives worldwide.Latest Immupharma Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | Northland Capital | – | 2018-04-17 16:35:00 17/04/2018 | – |
| – | Paul Summers | – | 2018-03-01 09:50:00 01/03/2018 | – |
| – | FinnCap | – | 2017-12-21 11:30:00 21/12/2017 | – |
| – | FinnCap | – | 2017-12-12 08:00:00 12/12/2017 | – |
| – | Harvey Jones | – | 2017-10-09 15:30:00 09/10/2017 | – |
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
Immupharma Overview
ImmuPharma PLC is a pharmaceutical development company focusing on developing novel medicines in specialist markets with serious unmet need. Lupuzor is the company's most advanced drug in development and is a treatment for lupus, a life threatening autoimmune disease and has now completed dosing Lupus patients in its Phase III pivotal trial. This is only part of our story as our scientists and researchers are developing drugs to make life changing difference to peoples lives worldwide.Latest Immupharma Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | Northland Capital | – | 2018-04-17 16:35:00 17/04/2018 | – |
| – | Paul Summers | – | 2018-03-01 09:50:00 01/03/2018 | – |
| – | FinnCap | – | 2017-12-21 11:30:00 21/12/2017 | – |
| – | FinnCap | – | 2017-12-12 08:00:00 12/12/2017 | – |
| – | Harvey Jones | – | 2017-10-09 15:30:00 09/10/2017 | – |